Researchers Resolved Rubredoxin at Record 0.43 Å Resolution
The record-setting protein structure could accelerate the engineering of customized drugs and designer enzymes.
Updated on Oct. 6, 2026 in Life Sciences
Live Poll
Does the potential for new medical breakthroughs justify the costs of advanced high-resolution protein research?
Scientists have determined the structure of the protein rubredoxin at a resolution of 0.43 Ångström. This measurement marks the highest resolution ever recorded for any protein structure.
Why it matters
Higher resolution data allows for a more granular understanding of atomic interactions, which is essential for the development of designer enzymes and precise medical therapies. This finding, achieved at the PETRA III facility, establishes a new benchmark for structural biology capabilities.
The team achieved a 0.43 Å resolution by using a 0.5 MegaGray absorbed radiation dose, significantly lower than the 20 MegaGray conventional limit. They utilized large 600 by 500 by 250 micrometer crystals and Cadmium Telluride detectors, which offer 5 times the quantum efficiency of standard sensors.
The players
Deutsches Elektronen-Synchrotron
A German research center operating the PETRA III storage ring used for high-energy physics and structural biology.
European Molecular Biology Laboratory
An intergovernmental research organization that operates the P14 beamline used for this data collection.
The details
Researchers at the PETRA III storage ring in Hamburg determined the structure by firing X-rays at rubredoxin crystals. To prevent radiation damage—a process where high-energy X-rays break chemical bonds in the sample—the team used a top-hat beam intensity profile, a technique that spreads the energy uniformly across the beam. A Cadmium Telluride detector, a semiconductor device that converts X-ray photons directly into electrical signals, captured the diffraction patterns with high sensitivity.
Timeline
October 6, 2026: The study was published in Acta Crystallographica Section D.
The Tech Race
This development pushes structural biology into the sub-half-Ångström regime, surpassing prior resolution limits that have constrained the study of atomic positions in larger biomolecules. It sets a new standard for data quality that competing synchrotron facilities will now seek to match.
This research is currently in the experimental stage and does not impact clinical medical products today. Over the coming years, the refined structural models enabled by this resolution will likely support drug designers in building more effective chemical inhibitors.
The takeaway
The successful imaging of rubredoxin at 0.43 Å proves that ultra-high resolution is achievable through improved beam profiles and sensor efficiency. Researchers and drug developers should watch for the adoption of these techniques in high-throughput pipelines for non-crystallized protein variants.
Further reading
Explore the latest developments in imaging and mapping at our Life Sciences section.
Source note: This article includes information reported by AZoM.
Live Poll
Does the potential for new medical breakthroughs justify the costs of advanced high-resolution protein research?
